After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CERS falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Cerus Corp is $308.64M. A total of 1.33 million shares were traded on the day, compared to an average of 1.24M shares.
In the most recent transaction, Gregory Dean A. bought 25,000 shares of CERS for 1.25 per share on Aug 25 ’25. After the transaction, the Director now owns 86,725 company shares. In a previous transaction on Mar 14 ’25, Jensen Chrystal sold 30,075 shares at 1.45 per share. CERS shares that Chief Legal Officer owns now total 783,294.
Among the insiders who sold shares, Jensen Chrystal disposed of 18,949 shares on Mar 13 ’25 at a per-share price of $1.45. This resulted in the Chief Legal Officer holding 813,369 shares of CERS after the transaction. In another insider transaction, Jayaraman Vivek K sold 46,004 shares at $1.45 per share on Mar 14 ’25. Company shares held by the Chief Operating Officer now total 1,431,326.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CERS has a high of $2.23 and a low of $1.12.
As of this writing, CERS has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.03. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CERS’s latest balance sheet shows that the firm has $129.36M in Cash & Short Term Investments as of fiscal 2021. There were $87.59M in debt and $78.56M in liabilities at the time. Its Book Value Per Share was $0.29, while its Total Shareholder’s Equity was $85.62M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CERS is Buy with a score of 4.20.
